InsidersTradesSigma
Follow the Corline Biomedical AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Corline Biomedical AB has logged 1 reports. Market capitalisation: €458.6m. The latest transaction was disclosed on 18 November 2025 (Purchase). Among the most active insiders: Henrik Nittmar. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Corline Biomedical AB 是一家专注于生物制药产品开发的公司。该公司致力于为严重疾病的治疗提供创新解决方案。